Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 trial evaluated a conditioning regimen incorporating venetoclax, carmustine, etoposide, cytarabine, and melphalan before stem ce…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity [Phase 2]
Phase 2 trial evaluating anakinra to prevent CAR-T cell–mediated neurotoxicity in Non-Hodgkin lymphoma; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study of CPI-613 (devimistat) in combination with bendamustine for relapsed/refractory T-cell non-Hodgkin lymphoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial of lenalidomide plus rituximab for Non-Hodgkin lymphoma was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation [Phase 2]
Phase 2 trial evaluating tocilizumab to prevent graft-versus-host disease after cord blood transplantation has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-90011 in participants with relapsed/refractory solid tumors and Non-Hodgkin lymphoma. Th…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma [Phase 1]
A Phase 1 study evaluating OPB-31121 in relapsed or refractory Non-Hodgkin's Lymphoma and Multiple Myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating mosunetuzumab with or without polatuzumab vedotin and obinutuzumab for untreated indolent B-cell non-Hod…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab [Phase 1]
This Phase 1 update describes adverse events and changes in disease state observed in pediatric participants and young adults (ages 18-25) w…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of VIP-152 in combination with Venetoclax and Prednisone in relapsed/refractory lymphoid malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation [Phase 1]
Phase 1 study evaluating itacitinib for prophylaxis of graft-versus-host disease and cytokine release syndrome after T-cell replete haploide…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors [Phase 2]
A Phase 2 trial evaluating α/β+-T lymphocyte-depleted donor grafts from HLA-mismatched donors in multiple hematologic malignancies was termi…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers [Phase 1]
Aplitabart (IGM-8444) Phase 1a/1b study in solid tumors and various hematologic cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL [Phase 1, Phase 2]
The trial evaluating allo GDA-201 natural killer cells for relapsed/refractory B-cell non-Hodgkin lymphoma was terminated, and the results h…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors [Phase 1]
Phase 1 trial of KT-333 in adults with refractory lymphomas and solid tumors reports safety, pharmacokinetics, pharmacodynamics, and prelimi…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
A US-based observational lymphoma registry sponsored by Celgene has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 open-label dose-escalation study evaluating safety, pharmacokinetics, pharmacodynamics, and early clinical activity of GSK3326595 in…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease [Phase 2]
Phase 2 trial evaluating an umbilical cord blood transplant regimen with cyclophosphamide, fludarabine, and total-body irradiation for hemat…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs
A completed clinical trial evaluating a multidisciplinary care program to ensure medication therapy for hematology patients receiving inject…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: IIT2020-20-SHIRAZIP-WALK: Nature Walks [NA]
The IIT2020-20-SHIRAZIP-WALK trial sponsored by Cedars-Sinai Medical Center has completed, studying breast cancer and several hematologic ma…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) [Phase 1]
Phase 1 trial evaluating LMP-, BARF1-, and EBNA1-specific cytotoxic T cells for EBV-positive lymphomas; Hodgkin and Non-Hodgkin lymphoma inc…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating DZD8586 in relapsed or refractory B-cell non-Hodgkin lymphoma (TAI-SHAN1).
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers [Phase 1]
This is a completed Phase 1 safety study of navitoclax (ABT-263) in combination with rituximab for CD20-positive lymphoid malignancies, incl…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL [Phase 1]
Phase 1 study update for ONO-7018 in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia, assessing safety, tolerabili…